OvCaRe Publications

1. Vergote, I., Trope, C.G., Amant, F., Kristensen, G.B., Ehlen, T., Johnson, N., Verheijen, R.H., van der Burg, M.E., Lacave, A.J., Panici, P.B., Kenter, G.G., Casado, A., Mendiola, C., Coens, C., Verleye, L., Stuart, G.C., Pecorelli, S., Reed, N.S.; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer N Engl J Med, 363(10):943-53. [PMID: 20818904]

2. Carey, M.S., Agarwal, R., Gilks, B., Swenerton, K., Kalloger, S., Santos, J., Ju, Z., Lu, Y., Zhang, F., Coombes, K.R., Miller, D., Huntsman, D., Mills, G.B. and Hennessy, B.T. (2010) Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy Clin Cancer Res, 16: p. 2852-60. [PMID: 20460476]

3. Chen, J., An, B.S., So, W.K., Cheng, L., Hammond, G.L. and Leung, P.C. (2010) Gonadotropin-releasing hormone-I-mediated activation of progesterone receptor contributes to gonadotropin alpha-subunit expression in mouse gonadotrophs Endocrinology, 151: p. 1204-11. [PMID: 20051488]

4. Cheung, L.W., Leung, P.C. and Wong, A.S. (2010) Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer Oncogene, 29: p. 2427-40. [PMID: 20118984]

5. Clarke, B.A. and Gilks, C.B. (2010) Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type J Clin Pathol, 63: p. 410-5. [PMID: 20418232]

6. Guo, J., Schally, A.V., Zarandi, M., Varga, J. and Leung, P.C. (2010) Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway Reprod Biol Endocrinol, 8: p. 54. [PMID: 20509930]

7. Kim, K.Y., Kim, S.U., Leung, P.C., Jeung, E.B. and Choi, K.C. (2010) Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth Cancer Sci. [PMID: 20132217]

8. Kobel, M., Kalloger, S.E., Baker, P.M., Ewanowich, C.A., Arseneau, J., Zherebitskiy, V., Abdulkarim, S., Leung, S., Duggan, M.A., Fontaine, D., Parker, R., Huntsman, D.G. and Gilks, C.B. (2010) Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible: A Transcanadian Study Am J Surg Pathol. [PMID: 20505499]

9. Kobel, M., Kalloger, S.E., Huntsman, D.G., Santos, J.L., Swenerton, K.D., Seidman, J.D. and Gilks, C.B. (2010) Differences in tumor type in low-stage versus high-stage ovarian carcinomas Int J Gynecol Pathol, 29: p. 203-11. [PMID: 20407318]

10. Lau, M.T., Wong, A.S. and Leung, P.C. (2010) Gonadotropins Induce Tumor Cell Migration and Invasion by Increasing Cyclooxygenases Expression and Prostaglandin E2 Production in Human Ovarian Cancer Cells Endocrinology. [PMID: 20392831]

11. Wang, T.T., Wu, Y.T., Dong, M.Y., Sheng, J.Z., Leung, P.C. and Huang, H.F. (2010) G546A polymorphism of growth differentiation factor-9 contributes to the poor outcome of ovarian stimulation in women with diminished ovarian reserve Fertil Steril. [PMID: 20451184]

12. Webb, J.R., Wick, D.A., Nielsen, J.S., Tran, E., Milne, K., McMurtrie, E. and Nelson, B.H. (2010) Profound elevation of CD8(+) T cells expressing the intraepithelial lymphocyte marker CD103 (alpha(E)/beta(7) Integrin) in high-grade serous ovarian cancer Gynecol Oncol. [PMID: 20541243]

13. Zhang, Y., Huang, Q., Cheng, J.C., Nishi, Y., Yanase, T., Huang, H.F. and Leung, P.C. (2010) Homeobox A7 increases cell proliferation by up-regulation of epidermal growth factor receptor expression in human granulosa cells Reprod Biol Endocrinol, 8: p. 61. [PMID: 20540809]

14. Gainford, M.C., Tinker, A., Carter, J., Petru, E., Nicklin, J., Quinn, M., Hammond, I., Elit, L., Lenhard, M. and Friedlander, M. (2010). Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. an australia new zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) study Int J Gynecol Cancer, 20: p. 75-81. [PMID: 20130506]

15. Gilks, C.B. (2010). Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma J Oncol, 2010: p. 740968. [PMID: 20069115]

16. Goya, R., Sun, M.G., Morin, R.D., Leung, G., Ha, G., Wiegand, K.C., Senz, J., Crisan, A., Marra, M.A., Hirst, M., Huntsman, D., Murphy, K.P., Aparicio, S. and Shah, S.P. (2010). SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors Bioinformatics, 26: p. 730-6. [PMID: 20130035]

17. Kobel, M., Kalloger, S.E., Santos, J.L., Huntsman, D.G., Gilks, C.B. and Swenerton, K.D. (2010). Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications Gynecol Oncol, 116: p. 50-6. [PMID: 19822358]

18. Mackay, H.J., Tinker, A., Winquist, E., Thomas, G., Swenerton, K., Oza, A., Sederias, J., Ivy, P. and Eisenhauer, E.A. (2010). A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184 Gynecol Oncol, 116: p. 163-7. [PMID: 19740535]

19 Madore, J., Ren, F., Filali-Mouhim, A., Sanchez, L., Kobel, M., Tonin, P.N., Huntsman, D., Provencher, D.M. and Mes-Masson, A.M. (2010). Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma J Pathol, 220: p. 392-400. [PMID: 19967725]

20. Maines-Bandiera, S., Woo, M.M., Borugian, M., Molday, L.L., Hii, T., Gilks, B., Leung, P.C., Molday, R.S. and Auersperg, N. (2010). Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer Int J Gynecol Cancer, 20: p. 16-22. [PMID: 20130498]

21. Tabrizi, A.D., Kalloger, S.E., Kobel, M., Cipollone, J., Roskelley, C.D., Mehl, E. and Gilks, C.B. (2010). Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases Int J Gynecol Pathol, 29: p. 99-107. [PMID: 20173494]

22. Zheng, J., Mercado-Uribe, I., Rosen, D.G., Chang, B., Liu, P., Yang, G., Malpica, A., Noara, H., Auersperg, N., Mills, G.B., Bast, R.C. and Liu, J. (2010). Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment Cell Cycle, 9: p. 140-6. [PMID: 20016289]

23. An, B.S., Poon, S.L., So, W.K., Hammond, G.L. and Leung, P.C. (2009). Rapid effect of GNRH1 on follicle-stimulating hormone beta gene expression in LbetaT2 mouse pituitary cells requires the progesterone receptor Biol Reprod, 81: p. 243-9. [PMID: 19357364]

24. Chen, J., An, B.S., Cheng, L., Hammond, G.L. and Leung, P.C. (2009). Gonadotropin-releasing hormone-mediated phosphorylation of estrogen receptor-alpha contributes to fosB expression in mouse gonadotrophs Endocrinology, 150: p. 4583-93. [PMID: 19574399]

25. Choi, J.H., Chen, C.L., Poon, S.L., Wang, H.S. and Leung, P.C. (2009). Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway Endocr Relat Cancer, 16: p. 179-88. [PMID: 19022848]

26. Clarke, B., Tinker, A.V., Lee, C.H., Subramanian, S., van de Rijn, M., Turbin, D., Kalloger, S., Han, G., Ceballos, K., Cadungog, M.G., Huntsman, D.G., Coukos, G. and Gilks, C.B. (2009). Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss Mod Pathol, 22: p. 393-402. [PMID: 19060844]

27. Espinosa, I., Beck, A.H., Lee, C.H., Zhu, S., Montgomery, K.D., Marinelli, R.J., Ganjoo, K.N., Nielsen, T.O., Gilks, C.B., West, R.B. and van de Rijn, M. (2009). Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma Am J Pathol, 174: p. 2347-56. [PMID: 19443701]

28. Etemadmoghadam, D., deFazio, A., Beroukhim, R., Mermel, C., George, J., Getz, G., Tothill, R., Okamoto, A., Raeder, M.B., Harnett, P., Lade, S., Akslen, L.A., Tinker, A.V., Locandro, B., Alsop, K., Chiew, Y.E., Traficante, N., Fereday, S., Johnson, D., Fox, S., Sellers, W., Urashima, M., Salvesen, H.B., Meyerson, M. and Bowtell, D. (2009). Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas Clin Cancer Res, 15: p. 1417-27. [PMID: 19193619]

29. Gilks, C.B. and Prat, J. (2009). Ovarian carcinoma pathology and genetics: recent advances Hum Pathol, 40: p. 1213-23. [PMID: 19552940]

30. Huang, Q., Cheung, A.P., Zhang, Y., Huang, H.F., Auersperg, N. and Leung, P.C. (2009). Effects of growth differentiation factor 9 on cell cycle regulators and ERK42/44 in human granulosa cell proliferation Am J Physiol Endocrinol Metab, 296: p. E1344-53. [PMID: 19366876]

31. Klausen, C., Leung, P.C. and Auersperg, N. (2009). Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin Mol Cancer Res, 7: p. 1425-37. [PMID: 19723874]

32. Kobel, M., Gilks, C.B. and Huntsman, D.G. (2009). Adult-type granulosa cell tumors and FOXL2 mutation Cancer Res, 69: p. 9160-2. [PMID: 19996294]

33. Kobel, M., Gilks, C.B. and Huntsman, D.G. (2009). Dicer and Drosha in ovarian cancer N Engl J Med, 360: p. 1150-1; author reply 1151. [PMID: 19279349]

34. Kobel, M., Kalloger, S.E., Carrick, J., Huntsman, D., Asad, H., Oliva, E., Ewanowich, C.A., Soslow, R.A. and Gilks, C.B. (2009). A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary Am J Surg Pathol, 33: p. 14-21. [PMID: 18830127]

35. Kobel, M., Xu, H., Bourne, P.A., Spaulding, B.O., Shih Ie, M., Mao, T.L., Soslow, R.A., Ewanowich, C.A., Kalloger, S.E., Mehl, E., Lee, C.H., Huntsman, D. and Gilks, C.B. (2009). IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype Mod Pathol, 22: p. 469-75. [PMID: 19136932]

36. Lee, C.H., Subramanian, S., Beck, A.H., Espinosa, I., Senz, J., Zhu, S.X., Huntsman, D., van de Rijn, M. and Gilks, C.B. (2009). MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary PLoS ONE, 4: p. e7314. [PMID: 19798417]

37. Lin, Q., Poon, S.L., Chen, J., Cheng, L., HoYuen, B. and Leung, P.C. (2009). Leptin interferes with 3',5'-cyclic adenosine monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells Reprod Biol Endocrinol, 7: p. 115. [PMID: 19849856]

38. Liu, J., Maccalman, C.D., Wang, Y.L. and Leung, P.C. (2009). Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways Mol Endocrinol, 23: p. 1014-21. [PMID: 19372239]

39. Liu, P., Khurana, A., Rattan, R., He, X., Kalloger, S., Dowdy, S., Gilks, B. and Shridhar, V. (2009). Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer Cancer Res, 69: p. 4843-50. [PMID: 19487294]

40. McAlpine, J.N., Wiegand, K.C., Vang, R., Ronnett, B.M., Adamiak, A., Kobel, M., Kalloger, S.E., Swenerton, K.D., Huntsman, D.G., Gilks, C.B. and Miller, D.M. (2009). HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy BMC Cancer, 9: p. 433. [PMID: 20003286]

41. Milne, K., Kobel, M., Kalloger, S.E., Barnes, R.O., Gao, D., Gilks, C.B., Watson, P.H. and Nelson, B.H. (2009). Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors PLoS ONE, 4: p. e6412. [PMID: 19641607]

42. Nelson, B.H. (2009). IDO and outcomes in ovarian cancer Gynecol Oncol, 115: p. 179-80. [PMID: 19822256]

43. Ota, T., Klausen, C., Salamanca, M.C., Woo, H.L., Leung, P.C. and Auersperg, N. (2009). Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells Differentiation, 77: p. 162-71. [PMID: 19281776]

44. Park, D.W., Choi, K.C., MacCalman, C.D. and Leung, P.C. (2009). Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase Reprod Biol Endocrinol, 7: p. 81. [PMID: 19656390]

45. Park, S.H., Kim, K.Y., An, B.S., Choi, J.H., Jeung, E.B., Leung, P.C. and Choi, K.C. (2009). Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38 J Reprod Dev, 55: p. 23-9. [PMID: 18854640]

46. Poon, S.L., Hammond, G.T. and Leung, P.C. (2009). Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion Mol Endocrinol, 23: p. 1646-56. [PMID: 19608641]

47. Salvador, S., Gilks, B., Kobel, M., Huntsman, D., Rosen, B. and Miller, D. (2009). The fallopian tube: primary site of most pelvic high-grade serous carcinomas Int J Gynecol Cancer, 19: p. 58-64. [PMID: 19258943]

48. Schrader, K.A., Gorbatcheva, B., Senz, J., Heravi-Moussavi, A., Melnyk, N., Salamanca, C., Maines-Bandiera, S., Cooke, S.L., Leung, P., Brenton, J.D., Gilks, C.B., Monahan, J. and Huntsman, D.G. (2009). The specificity of the FOXL2 c.402C>G Somatic mutation: a survey of solid tumors PLoS ONE, 4: p. e7988. [PMID: 19956657]

49. Shah, S.P., Kobel, M., Senz, J., Morin, R.D., Clarke, B.A., Wiegand, K.C., Leung, G., Zayed, A., Mehl, E., Kalloger, S.E., Sun, M., Giuliany, R., Yorida, E., Jones, S., Varhol, R., Swenerton, K.D., Miller, D., Clement, P.B., Crane, C., Madore, J., Provencher, D., Leung, P., Defazio, A., Khattra, J., Turashvili, G., Zhao, Y., Zeng, T., Glover, J.N., Vanderhyden, B., Zhao, C., Parkinson, C.A., Jimenez-Linan, M., Bowtell, D.D., Mes-Masson, A.M., Brenton, J.D., Aparicio, S.A., Boyd, N., Hirst, M., Gilks, C.B., Marra, M. and Huntsman, D.G. (2009). Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary N Engl J Med, epub ahead of print. [PMID: 19516027]

50. Shi, F.T., Cheung, A.P., Huang, H.F. and Leung, P.C. (2009). Effects of endogenous growth differentiation factor 9 on activin A-induced inhibin B production in human granulosa-lutein cells J Clin Endocrinol Metab, 94: p. 5108-16. [PMID: 19846738]

51. Shi, F.T., Cheung, A.P. and Leung, P.C. (2009). Growth differentiation factor 9 enhances activin a-induced inhibin B production in human granulosa cells Endocrinology, 150: p. 3540-6. [PMID: 19423755]

52. Tang, L., Zhang, Y., Pan, H., Luo, Q., Zhu, X.M., Dong, M.Y., Leung, P.C., Sheng, J.Z. and Huang, H.F. (2009). Involvement of cyclin B1 in progesterone-mediated cell growth inhibition, G2/M cell cycle arrest, and apoptosis in human endometrial cell Reprod Biol Endocrinol, 7: p. 144. [PMID: 19968870]

53. Wu, H.M., Cheng, J.C., Wang, H.S., Huang, H.Y., MacCalman, C.D. and Leung, P.C. (2009). Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha Cancer Res, 69: p. 4202-8. [PMID: 19366794]

54. Wu, H.M., Wang, H.S., Huang, H.Y., Soong, Y.K., MacCalman, C.D. and Leung, P.C. (2009). GnRH signaling in intrauterine tissues Reproduction, 137: p. 769-77. [PMID: 19208750]

55. Anglesio, M.S., Arnold, J.M., George, J., Tinker, A.V., Tothill, R., Waddell, N., Simms, L., Locandro, B., Fereday, S., Traficante, N., Russell, P., Sharma, R., Birrer, M.J., deFazio, A., Chenevix-Trench, G. and Bowtell, D.D. (2008). Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors Mol Cancer Res, 6: p. 1678-90. [PMID: 19010816]

56. Astanehe, A., Arenillas, D., Wasserman, W.W., Leung, P.C., Dunn, S.E., Davies, B.R., Mills, G.B. and Auersperg, N. (2008). Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer J Cell Sci, 121: p. 664-74. [PMID: 18270270]

57. Auersperg, N., Woo, M.M. and Gilks, C.B. (2008). The origin of ovarian carcinomas: a developmental view Gynecol Oncol, 110: p. 452-4. [PMID: 18603285]

58. Brown, L.A., Kalloger, S.E., Miller, M.A., Shih Ie, M., McKinney, S.E., Santos, J.L., Swenerton, K., Spellman, P.T., Gray, J., Gilks, C.B. and Huntsman, D.G. (2008). Amplification of 11q13 in ovarian carcinoma Genes Chromosomes Cancer, 47: p. 481-9. [PMID: 18314909]

59. Dimple, C., Nair, S.S., Rajhans, R., Pitcheswara, P.R., Liu, J., Balasenthil, S., Le, X.F., Burow, M.E., Auersperg, N., Tekmal, R.R., Broaddus, R.R. and Vadlamudi, R.K. (2008). Role of PELP1/MNAR signaling in ovarian tumorigenesis Cancer Res, 68: p. 4902-9. [PMID: 18559538]

60. Gilks, C.B., Ionescu, D.N., Kalloger, S.E., Kobel, M., Irving, J., Clarke, B., Santos, J., Le, N., Moravan, V. and Swenerton, K. (2008). Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma Hum Pathol, 39: p. 1239-51. [PMID: 18602670]

61. Han, G., Gilks, C.B., Leung, S., Ewanowich, C.A., Irving, J.A., Longacre, T.A. and Soslow, R.A. (2008). Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases Am J Surg Pathol, 32: p. 955-64. [PMID: 18460981]

62. Hennessy, B.T., Murph, M., Nanjundan, M., Carey, M., Auersperg, N., Almeida, J., Coombes, K.R., Liu, J., Lu, Y., Gray, J.W. and Mills, G.B. (2008). Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead Adv Exp Med Biol, 617: p. 23-40. [PMID: 18497028]

63. Hong, I.S., Cheung, A.P. and Leung, P.C. (2008). Gonadotropin-releasing hormones I and II induce apoptosis in human granulosa cells J Clin Endocrinol Metab, 93: p. 3179-85. [PMID: 18477660]

64. Hoskins, P.J., Le, N., Ellard, S., Lee, U., Martin, L.A., Swenerton, K.D. and Tinker, A.V. (2008). Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience Gynecol Oncol, 108: p. 58-62. [PMID: 17935761]

65. Kobel, M., Huntsman, D. and Gilks, C.B. (2008). Critical molecular abnormalities in high-grade serous carcinoma of the ovary Expert Rev Mol Med, 10: p. e22. [PMID: 18671886]

66. Kobel, M., Kalloger, S.E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N.J., Ionescu, D.N., Rajput, A., Prentice, L.M., Miller, D., Santos, J., Swenerton, K., Gilks, C.B. and Huntsman, D. (2008). Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Med, 5: p. e232. [PMID: 19053170]

67. McIntosh, M. anderson, G., Drescher, C., Hanash, S., Urban, N., Brown, P., Gambhir, S.S., Coukos, G., Laird, P.W., Nelson, B. and Palmer, C. (2008). Ovarian cancer early detection claims are biased Clin Cancer Res, 14: p. 7574; author reply 7577-9. [PMID: 18948385]

68. Milne, K., Barnes, R.O., Girardin, A., Mawer, M.A., Nesslinger, N.J., Ng, A., Nielsen, J.S., Sahota, R., Tran, E., Webb, J.R., Wong, M.Q., Wick, D.A., Wray, A., McMurtrie, E., Kobel, M., Kalloger, S.E., Gilks, C.B., Watson, P.H. and Nelson, B.H. (2008). Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer PLoS ONE, 3: p. e3409. [PMID: 18923710]

69. Natesampillai, S., Kerkvliet, J., Leung, P.C. and Veldhuis, J.D. (2008). Regulation of Kruppel-like factor 4, 9, and 13 genes and the steroidogenic genes LDLR, StAR, and CYP11A in ovarian granulosa cells Am J Physiol Endocrinol Metab, 294: p. E385-91. [PMID: 18056793]

70. Nelson, B.H. (2008). The impact of T-cell immunity on ovarian cancer outcomes Immunol Rev, 222: p. 101-16. [PMID: 18363996]

71. Ota, T., Asahina, H., Park, S.H., Huang, Q., Minegishi, T., Auersperg, N. and Leung, P.C. (2008). HOX cofactors expression and regulation in the human ovary Reprod Biol Endocrinol, 6: p. 49. [PMID: 18973687]

72. Palmer, C., Duan, X., Hawley, S., Scholler, N., Thorpe, J.D., Sahota, R.A., Wong, M.Q., Wray, A., Bergan, L.A., Drescher, C.W., McIntosh, M.W., Brown, P.O., Nelson, B.H. and Urban, N. (2008). Systematic evaluation of candidate blood markers for detecting ovarian cancer PLoS ONE, 3: p. e2633. [PMID: 18612378]

73. Pinke, D.E., Kalloger, S.E., Francetic, T., Huntsman, D.G. and Lee, J.M. (2008). The prognostic significance of elongation factor eEF1A2 in ovarian cancer Gynecol Oncol, 108: p. 561-8. [PMID: 18164751]

74. Press, J.Z., De Luca, A., Boyd, N., Young, S., Troussard, A., Ridge, Y., Kaurah, P., Kalloger, S.E., Blood, K.A., Smith, M., Spellman, P.T., Wang, Y., Miller, D.M., Horsman, D., Faham, M., Gilks, C.B., Gray, J. and Huntsman, D.G. (2008). Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities BMC Cancer, 8: p. 17. [PMID: 18208621]

75. Press, J.Z., Kenyon, J.A., Xue, H., Miller, M.A., De Luca, A., Miller, D.M., Huntsman, D.G., Gilks, C.B., McAlpine, J.N. and Wang, Y.Z. (2008). Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy Gynecol Oncol, 110: p. 256-64. [PMID: 18547621]

76. Ronnett, B.M., Yemelyanova, A.V., Vang, R., Gilks, C.B., Miller, D., Gravitt, P.E. and Kurman, R.J. (2008). Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms Am J Surg Pathol, 32: p. 1835-53. [PMID: 18813124]

77. Salvador, S., Rempel, A., Soslow, R.A., Gilks, B., Huntsman, D. and Miller, D. (2008). Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma Gynecol Oncol, 110: p. 408-17. [PMID: 18597838]

78. Singh, R., Graves, M.L., Roskelley, C.D., Giritharan, G. and Rajamahendran, R. (2008). Gonadotropin releasing hormone receptor gene and protein expression and immunohistochemical localization in bovine uterus and oviducts Domest Anim Endocrinol, 34: p. 319-26. [PMID: 18035513]

79. Sun, Y., Wong, N., Guan, Y., Salamanca, C.M., Cheng, J.C., Lee, J.M., Gray, J.W. and Auersperg, N. (2008). The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas Int J Cancer, 123: p. 1761-9. [PMID: 18661515]

80. Tothill, R.W., Tinker, A.V., George, J., Brown, R., Fox, S.B., Lade, S., Johnson, D.S., Trivett, M.K., Etemadmoghadam, D., Locandro, B., Traficante, N., Fereday, S., Hung, J.A., Chiew, Y.E., Haviv, I., Gertig, D., DeFazio, A. and Bowtell, D.D. (2008). Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clin Cancer Res, 14: p. 5198-208. [PMID: 18698038]

81. Weichert, W., Denkert, C., Noske, A., Darb-Esfahani, S., Dietel, M., Kalloger, S.E., Huntsman, D.G. and Kobel, M. (2008). Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas Neoplasia, 10: p. 1021-7. [PMID: 18714364]

82. Woo, M.M., Salamanca, C.M., Miller, M., Symowicz, J., Leung, P.C., Oliveira, C., Ehlen, T.G., Gilks, C.B., Huntsman, D. and Auersperg, N. (2008). Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas Int J Gynecol Cancer, 18: p. 1234-47. [PMID: 18217967]

83. Woo, M.M., Salamanca, C.M., Symowicz, J., Stack, M.S., Miller, D.M., Leung, P.C., Gilks, C.B. and Auersperg, N. (2008). SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells Gynecol Oncol, 111: p. 125-31. [PMID: 18678400]

84. Wu, C., Cipollone, J., Maines-Bandiera, S., Tan, C., Karsan, A., Auersperg, N. and Roskelley, C.D. (2008). The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression Differentiation, 76: p. 193-205. [PMID: 17608733]

85. Chen, C.L., Cheung, L.W., Lau, M.T., Choi, J.H., Auersperg, N., Wang, H.S., Wong, A.S. and Leung, P.C. (2007). Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion Endocrine, 31: p. 311-20. [PMID: 17906381]

86. Graves, M.L., Zhou, L., MacDonald, G., Mueller, C.R. and Roskelley, C.D. (2007). Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells FEBS Lett, 581: p. 1825-33. [PMID: 17434164]

87. Guan, Y., Kuo, W.L., Stilwell, J.L., Takano, H., Lapuk, A.V., Fridlyand, J., Mao, J.H., Yu, M., Miller, M.A., Santos, J.L., Kalloger, S.E., Carlson, J.W., Ginzinger, D.G., Celniker, S.E., Mills, G.B., Huntsman, D.G. and Gray, J.W. (2007). Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer Clin Cancer Res, 13: p. 5745-55. [PMID: 17908964]

88. He, X., Pool, M., Darcy, K.M., Lim, S.B., Auersperg, N., Coon, J.S. and Beck, W.T. (2007). Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro Oncogene, 26: p. 4961-8. [PMID: 17310993]

89. Leung, P.C. and Choi, J.H. (2007). Endocrine signaling in ovarian surface epithelium and cancer Hum Reprod Update, 13: p. 143-62. [PMID: 17071638]

90. Li, P., Maines-Bandiera, S., Kuo, W.L., Guan, Y., Sun, Y., Hills, M., Huang, G., Collins, C.C., Leung, P.C., Gray, J.W. and Auersperg, N. (2007). Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression Int J Cancer, 120: p. 1863-73. [PMID: 17266044]

91. Ota, T., Gilks, C.B., Longacre, T., Leung, P.C. and Auersperg, N. (2007). HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features Reprod Sci, 14: p. 605-14. [PMID: 17959889]

92. Prentice, L.M., Klausen, C., Kalloger, S., Kobel, M., McKinney, S., Santos, J.L., Kenney, C., Mehl, E., Gilks, C.B., Leung, P., Swenerton, K., Huntsman, D.G. and Aparicio, S.A. (2007). Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma BMC Med, 5: p. 33. [PMID: 18005407]

93. Schumacher, J.J., Dings, R.P., Cosin, J., Subramanian, I.V., Auersperg, N. and Ramakrishnan, S. (2007). Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells Cancer Res, 67: p. 3683-90. [PMID: 17440080]

94. Thorpe, J.D., Duan, X., Forrest, R., Lowe, K., Brown, L., Segal, E., Nelson, B. anderson, G.L., McIntosh, M. and Urban, N. (2007). Effects of blood collection conditions on ovarian cancer serum markers PLoS ONE, 2: p. e1281. [PMID: 18060075]

95. Tinker, A.V., Gebski, V., Fitzharris, B., Buck, M., Stuart-Harris, R., Beale, P., Goldrick, A. and Rischin, D. (2007). Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01 Gynecol Oncol, 104: p. 647-53. [PMID: 17079006]

96. Wong, A.S. and Leung, P.C. (2007). Role of endocrine and growth factors on the ovarian surface epithelium J Obstet Gynaecol Res, 33: p. 3-16. [PMID: 17212660]

97. Yang, T., Wall, E.M., Milne, K., Theiss, P., Watson, P. and Nelson, B.H. (2007). CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism Clin Cancer Res, 13: p. 7172-80. [PMID: 18056198]

98. Ahmed, N., Maines-Bandiera, S., Quinn, M.A., Unger, W.G., Dedhar, S. and Auersperg, N. (2006). Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium Am J Physiol Cell Physiol, 290: p. C1532-42. [PMID: 16394028]

99. Brewer, M., Kirkpatrick, N.D., Wharton, J.T., Wang, J., Hatch, K., Auersperg, N., Utzinger, U., Gershenson, D., Bast, R. and Zou, C. (2006). 4-HPR modulates gene expression in ovarian cells Int J Cancer, 119: p. 1005-13. [PMID: 16570282]

100. Brown, L.A., Irving, J., Parker, R., Kim, H., Press, J.Z., Longacre, T.A., Chia, S., Magliocco, A., Makretsov, N., Gilks, B., Pollack, J. and Huntsman, D. (2006). Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas Gynecol Oncol, 100: p. 264-70. [PMID: 16236351]

101. Cheung, L.W., Au, S.C., Cheung, A.N., Ngan, H.Y., Tombran-Tink, J., Auersperg, N. and Wong, A.S. (2006). Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells Endocrinology, 147: p. 4179-91. [PMID: 16777976]

102. Choi, J.H., Choi, K.C., Auersperg, N. and Leung, P.C. (2006). Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells Endocr Relat Cancer, 13: p. 641-51. [PMID: 16728589]

103. Choi, J.H., Choi, K.C., Auersperg, N. and Leung, P.C. (2006). Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells Cancer Res, 66: p. 3912-20. [PMID: 16585220]

104. Choi, J.H., Gilks, C.B., Auersperg, N. and Leung, P.C. (2006). Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary J Clin Endocrinol Metab, 91: p. 4562-70. [PMID: 16954155]

105. de Lemos, M.L., Hamata, L., Conklin, J. and Swenerton, K. (2006). Potential underdosing of carboplatin in gynecological malignancies Gynecol Oncol, 102: p. 599. [PMID: 16815537]

106. de Lemos, M.L., Hsieh, T., Hamata, L., Levin, A., Swenerton, K., Djurdjev, O., Vu, T., Hu, F., Conklin, J. and Malfair Taylor, S.C. (2006). Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies Gynecol Oncol, 103: p. 1063-9. [PMID: 16875719]

107. Erkanli, A., Taylor, D.D., Dean, D., Eksir, F., Egger, D., Geyer, J., Nelson, B.H., Stone, B., Fritsche, H.A. and Roden, R.B. (2006). Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection Cancer Res, 66: p. 1792-8. [PMID: 16452240]

108. Kim, K.Y., Choi, K.C., Auersperg, N. and Leung, P.C. (2006). Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway Endocr Relat Cancer, 13: p. 211-20. [PMID: 16601289]

109. Mao, T.L., Hsu, C.Y., Yen, M.J., Gilks, B., Sheu, J.J., Gabrielson, E., Vang, R., Cope, L., Kurman, R.J., Wang, T.L. and Shih Ie, M. (2006). Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma Hum Pathol, 37: p. 1169-75. [PMID: 16938522]

110. Ota, T., Choi, K.B., Gilks, C.B., Leung, P.C. and Auersperg, N. (2006). Cell type- and stage-specific changes in HOXA7 protein expression in human ovarian folliculogenesis: possible role of GDF-9 Differentiation, 74: p. 1-10. [PMID: 16466395]

111. Plante, M., Lau, S., Brydon, L., Swenerton, K., LeBlanc, R. and Roy, M. (2006). Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report Gynecol Oncol, 101: p. 367-70. [PMID: 16542714]

112. Xu, G., Zhou, H., Wang, Q., Auersperg, N. and Peng, C. (2006). Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines Mol Cancer Res, 4: p. 235-46. [PMID: 16603637]

113. Auersperg, N. (2005). Re: "Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma" Gynecol Oncol, 97: p. 302-4; author reply 304-5. [PMID: 15790484]

114. Brewer, M., Wharton, J.T., Wang, J., McWatters, A., Auersperg, N., Gershenson, D., Bast, R. and Zou, C. (2005). In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer Gynecol Oncol, 98: p. 182-92. [PMID: 15907982]

115. Choi, J.H., Choi, K.C., Auersperg, N. and Leung, P.C. (2005). Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells Endocr Relat Cancer, 12: p. 407-21. [PMID: 15947112]

116. Dark, G.G., Calvert, A.H., Grimshaw, R., Poole, C., Swenerton, K., Kaye, S., Coleman, R., Jayson, G., Le, T., Ellard, S., Trudeau, M., Vasey, P., Hamilton, M., Cameron, T., Barrett, E., Walsh, W., McIntosh, L. and Eisenhauer, E.A. (2005). Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group J Clin Oncol, 23: p. 1859-66. [PMID: 15699482]

117. Ehlen, T.G., Hoskins, P.J., Miller, D., Whiteside, T.L., Nicodemus, C.F., Schultes, B.C. and Swenerton, K.D. (2005). A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer Int J Gynecol Cancer, 15: p. 1023-34. [PMID: 16343178]

118. Elishaev, E., Gilks, C.B., Miller, D., Srodon, M., Kurman, R.J. and Ronnett, B.M. (2005). Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms Am J Surg Pathol, 29: p. 281-94. [PMID: 15725796]

119. Feng, Q., Li, P., Salamanca, C., Huntsman, D., Leung, P.C. and Auersperg, N. (2005). Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis Cancer Res, 65: p. 8591-6. [PMID: 16204022]

120. Gilks, C.B., Vanderhyden, B.C., Zhu, S., van de Rijn, M. and Longacre, T.A. (2005). Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling Gynecol Oncol, 96: p. 684-94. [PMID: 15721412]

121. He, Q.Y., Zhou, Y., Wong, E., Ehlen, T.G., Auersperg, N., Chiu, J.F. and Wong, A.S. (2005). Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies Gynecol Oncol, 98: p. 68-76. [PMID: 15913737]

122. Kim, K.Y., Choi, K.C., Park, S.H., Auersperg, N. and Leung, P.C. (2005). Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation J Clin Endocrinol Metab, 90: p. 1670-7. [PMID: 15598681]

123. Le, L.H., Swenerton, K.D., Elit, L., Provencher, D.M., Stuart, G.C., Le, T., Lee, U., Rodgers, A., Pond, G.R., Hu, H. and Oza, A.M. (2005). Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies Int J Gynecol Cancer, 15: p. 799-806. [PMID: 16174227]

124. Lee, C.H., Huntsman, D.G., Cheang, M.C., Parker, R.L., Brown, L., Hoskins, P., Miller, D. and Gilks, C.B. (2005). Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma Int J Gynecol Pathol, 24: p. 147-52. [PMID: 15782071]

125. Lee, C.H., Xue, H., Sutcliffe, M., Gout, P.W., Huntsman, D.G., Miller, D.M., Gilks, C.B. and Wang, Y.Z. (2005). Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models Gynecol Oncol, 96: p. 48-55. [PMID: 15589579]

126. Ludwick, C., Gilks, C.B., Miller, D., Yaziji, H. and Clement, P.B. (2005). Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature Int J Gynecol Pathol, 24: p. 205-17. [PMID: 15968194]

127. Pon, Y.L., Auersperg, N. and Wong, A.S. (2005). Gonadotropins regulate N-cadherin-mediated human ovarian surface epithelial cell survival at both post-translational and transcriptional levels through a cyclic AMP/protein kinase A pathway J Biol Chem, 280: p. 15438-48. [PMID: 15701645]

128. Smith-Beckerman, D.M., Fung, K.W., Williams, K.E., Auersperg, N., Godwin, A.K. and Burlingame, A.L. (2005). Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer Mol Cell Proteomics, 4: p. 156-68. [PMID: 15591324]

129. Symowicz, J., Adley, B.P., Woo, M.M., Auersperg, N., Hudson, L.G. and Stack, M.S. (2005). Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells Cancer Res, 65: p. 2234-42. [PMID: 15781636]

130. Tai, C.J., Chang, S.J., Chien, L.Y., Leung, P.C. and Tzeng, C.R. (2005). Adenosine triphosphate induces activation of caspase-3 in apoptosis of human granulosa-luteal cells Endocr J, 52: p. 327-35. [PMID: 16006727]

131. Tinker, A.V., Bhagat, K., Swenerton, K.D. and Hoskins, P.J. (2005). Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience Gynecol Oncol, 98: p. 54-8. [PMID: 15904950]

132. Cheng, K.W., Lahad, J.P., Kuo, W.L., Lapuk, A., Yamada, K., Auersperg, N., Liu, J., Smith-McCune, K., Lu, K.H., Fishman, D., Gray, J.W. and Mills, G.B. (2004). The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers Nat Med, 10: p. 1251-6. [PMID: 15502842]

133. Choi, J.H., Choi, K.C., Auersperg, N. and Leung, P.C. (2004). Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells J Clin Endocrinol Metab, 89: p. 5508-16. [PMID: 15531506]

134. Gilks, C.B. (2004). Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data Int J Gynecol Pathol, 23: p. 200-5. [PMID: 15213595]

135. Kim, K.Y., Choi, K.C., Park, S.H., Chou, C.S., Auersperg, N. and Leung, P.C. (2004). Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells J Clin Endocrinol Metab, 89: p. 3020-6. [PMID: 15181093]

136. Liu, J., Yang, G., Thompson-Lanza, J.A., Glassman, A., Hayes, K., Patterson, A., Marquez, R.T., Auersperg, N., Yu, Y., Hahn, W.C., Mills, G.B. and Bast, R.C., Jr. (2004). A genetically defined model for human ovarian cancer Cancer Res, 64: p. 1655-63. [PMID: 14996724]

137. Maines-Bandiera, S.L., Huntsman, D., Lestou, V.S., Kuo, W.L., Leung, P.C., Horsman, R.D., Wong, A.S., Woo, M.M., Choi, K.K., Roskelley, C.D. and Auersperg, N. (2004). Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell line Differentiation, 72: p. 150-61. [PMID: 15157238]

138. Parker, R.L., Clement, P.B., Chercover, D.J., Sornarajah, T. and Gilks, C.B. (2004). Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases Int J Gynecol Pathol, 23: p. 265-72. [PMID: 15213603]

139. Ronnett, B.M., Kajdacsy-Balla, A., Gilks, C.B., Merino, M.J., Silva, E., Werness, B.A. and Young, R.H. (2004). Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior Hum Pathol, 35: p. 949-60. [PMID: 15297962]

140. Salamanca, C.M., Maines-Bandiera, S.L., Leung, P.C., Hu, Y.L. and Auersperg, N. (2004). Effects of epidermal growth factor/hydrocortisone on the growth and differentiation of human ovarian surface epithelium J Soc Gynecol Investig, 11: p. 241-51. [PMID: 15120699]

141. Tai, C.J., Chang, S.J., Leung, P.C. and Tzeng, C.R. (2004). Adenosine 5'-triphosphate activates nuclear translocation of mitogen-activated protein kinases leading to the induction of early growth response 1 and raf expression in human granulosa-luteal cells J Clin Endocrinol Metab, 89: p. 5189-95. [PMID: 15472225]

142. Wong, A.S., Roskelley, C.D., Pelech, S., Miller, D., Leung, P.C. and Auersperg, N. (2004). Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation Exp Cell Res, 299: p. 248-56. [PMID: 15302591]

143. Woo, M.M., Alkushi, A., Verhage, H.G., Magliocco, A.M., Leung, P.C., Gilks, C.B. and Auersperg, N. (2004). Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer Clin Cancer Res, 10: p. 7958-64. [PMID: 15585630]

144. Woo, M.M., Gilks, C.B., Verhage, H.G., Longacre, T.A., Leung, P.C. and Auersperg, N. (2004). Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts Gynecol Oncol, 93: p. 315-9. [PMID: 15099939]

145. Auersperg, N. (2003). Specific keynote: experimental models of epithelial ovarian carcinogenesis Gynecol Oncol, 88: p. S47-51; discussion S52-5. [PMID: 12586085]

146. Choi, K.C. and Auersperg, N. (2003). The ovarian surface epithelium: simple source of a complex disease Minerva Ginecol, 55: p. 297-314. [PMID: 14581855]

147. Choi, K.C., Auersperg, N. and Leung, P.C. (2003). Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium Reprod Biol Endocrinol, 1: p. 71. [PMID: 14577832]

148. Choi, K.C., Tai, C.J., Tzeng, C.R., Auersperg, N. and Leung, P.C. (2003). Adenosine triphosphate activates mitogen-activated protein kinase in pre-neoplastic and neoplastic ovarian surface epithelial cells Biol Reprod, 68: p. 309-15. [PMID: 12493727]

149. Foulkes, W.D., Narod, S.A., Swenerton, K., Panabaker, K. and Gilbert, L. (2003). Re: Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study J Natl Cancer Inst, 95: p. 1640. [PMID: 14600100]

150. Gilks, C.B., Alkushi, A., Yue, J.J., Lanvin, D., Ehlen, T.G. and Miller, D.M. (2003). Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases Int J Gynecol Pathol, 22: p. 29-36. [PMID: 12496695]

151. Hoskins, P.J., Swenerton, K.D., Pike, J.A., Lim, P., Aquino-Parsons, C., Wong, F. and Lee, N. (2003). Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy J Clin Oncol, 21: p. 3495-501. [PMID: 12972526]

152. Hughes-Davies, L., Huntsman, D., Ruas, M., Fuks, F., Bye, J., Chin, S.F., Milner, J., Brown, L.A., Hsu, F., Gilks, B., Nielsen, T., Schulzer, M., Chia, S., Ragaz, J., Cahn, A., Linger, L., Ozdag, H., Cattaneo, E., Jordanova, E.S., Schuuring, E., Yu, D.S., Venkitaraman, A., Ponder, B., Doherty, A., Aparicio, S., Bentley, D., Theillet, C., Ponting, C.P., Caldas, C. and Kouzarides, T. (2003). EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer Cell, 115: p. 523-35. [PMID: 14651845]

153. Khosravi, S. and Leung, P.C. (2003). Differential regulation of gonadotropin-releasing hormone (GnRH)I and GnRHII messenger ribonucleic acid by gonadal steroids in human granulosa luteal cells J Clin Endocrinol Metab, 88: p. 663-72. [PMID: 12574197]

154. Leung, P.C., Cheng, C.K. and Zhu, X.M. (2003). Multi-factorial role of GnRH-I and GnRH-II in the human ovary Mol Cell Endocrinol, 202: p. 145-53. [PMID: 12770744]

155. McCoy, M.L., Mueller, C.R. and Roskelley, C.D. (2003). The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer Reprod Biol Endocrinol, 1: p. 72. [PMID: 14613551]

156. Oza, A.M., Elit, L., Swenerton, K., Faught, W., Ghatage, P., Carey, M., McIntosh, L., Dorr, A., Holmlund, J.T. and Eisenhauer, E. (2003). Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116) Gynecol Oncol, 89: p. 129-33. [PMID: 12694666]

157. Piccart, M.J., Bertelsen, K., Stuart, G., Cassidy, J., Mangioni, C., Simonsen, E., James, K., Kaye, S., Vergote, I., Blom, R., Grimshaw, R., Atkinson, R., Swenerton, K., Trope, C., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J.A., Lhoas, F., Lidvall, B., Bacon, M., Birt, A. andersen, J., Zee, B., Paul, J., Pecorelli, S., Baron, B. and McGuire, W. (2003). Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer Int J Gynecol Cancer, 13 Suppl 2: p. 144-8. [PMID: 14656271]

158. Stone, B., Schummer, M., Paley, P.J., Thompson, L., Stewart, J., Ford, M., Crawford, M., Urban, N., O'Briant, K. and Nelson, B.H. (2003). Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q Int J Cancer, 104: p. 73-84. [PMID: 12532422]

159. Tanyi, J.L., Morris, A.J., Wolf, J.K., Fang, X., Hasegawa, Y., Lapushin, R., Auersperg, N., Sigal, Y.J., Newman, R.A., Felix, E.A., Atkinson, E.N. and Mills, G.B. (2003). The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer Cancer Res, 63: p. 1073-82. [PMID: 12615725]

160. Wong, A.S. and Auersperg, N. (2003). Ovarian surface epithelium: family history and early events in ovarian cancer Reprod Biol Endocrinol, 1: p. 70. [PMID: 14609432]

161. Zand, L., Qiang, F., Roskelley, C.D., Leung, P.C. and Auersperg, N. (2003). Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion In Vitro Cell Dev Biol Anim, 39: p. 178-82. [PMID: 14505428]

162. Auersperg, N., Ota, T. and Mitchell, G.W. (2002). Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches Int J Gynecol Cancer, 12: p. 691-703. [PMID: 12445245]

163. Auersperg, N. and Ziltener, H. (2002). Re: Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells J Natl Cancer Inst, 94: p. 1255-6. [PMID: 12189232]

164. Bilderback, T.R., Lee, F., Auersperg, N. and Rodland, K.D. (2002). Phosphatidylinositol 3-kinase-dependent, MEK- independent proliferation in response to CaR activation Am J Physiol Cell Physiol, 283: p. C282-8. [PMID: 12055097]

165. Brewer, M., Utzinger, U., Li, Y., Atkinson, E.N., Satterfield, W., Auersperg, N., Richards-Kortum, R., Follen, M. and Bast, R. (2002). Fluorescence spectroscopy as a biomarker in a cell culture and in a nonhuman primate model for ovarian cancer chemopreventive agents J Biomed Opt, 7: p. 20-6. [PMID: 11818008]

166. Cheng, C.K., Yeung, C.M., Chow, B.K. and Leung, P.C. (2002). Characterization of a new upstream GnRH receptor promoter in human ovarian granulosa-luteal cells Mol Endocrinol, 16: p. 1552-64. [PMID: 12089350]

167. Cheng, C.K., Yeung, C.M., Hoo, R.L., Chow, B.K. and Leung, P.C. (2002). Oct-1 is involved in the transcriptional repression of the gonadotropin-releasing hormone receptor gene Endocrinology, 143: p. 4693-701. [PMID: 12446597]

168. Choi, K.C., Kang, S.K., Tai, C.J., Auersperg, N. and Leung, P.C. (2002). Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells J Clin Endocrinol Metab, 87: p. 2245-53. [PMID: 11994371]

169. Lee, P.S., Buchan, A.M., Hsueh, A.J., Yuen, B.H. and Leung, P.C. (2002). Intracellular calcium mobilization in response to the activation of human wild-type and chimeric gonadotropin receptors Endocrinology, 143: p. 1732-40. [PMID: 11956155]

170. Manzano, R.G., Montuenga, L.M., Dayton, M., Dent, P., Kinoshita, I., Vicent, S., Gardner, G.J., Nguyen, P., Choi, Y.H., Trepel, J., Auersperg, N. and Birrer, M.J. (2002). CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential Oncogene, 21: p. 4435-47. [PMID: 12080474]

171. Mayer, C., Miller, D.M. and Ehlen, T.G. (2002). Peritoneal implantation of squamous cell carcinoma following rupture of a dermoid cyst during laparoscopic removal Gynecol Oncol, 84: p. 180-3. [PMID: 11748999]

172. Roskelley, C.D. and Bissell, M.J. (2002). The dominance of the microenvironment in breast and ovarian cancer Semin Cancer Biol, 12: p. 97-104. [PMID: 12027581]

173. Seiden, M.V., Swenerton, K.D., Matulonis, U., Campos, S., Rose, P., Batist, G., Ette, E., Garg, V., Fuller, A., Harding, M.W. and Charpentier, D. (2002). A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy Gynecol Oncol, 86: p. 302-10. [PMID: 12217752]

174. Tanyi, J.L., Lapushin, R., Eder, A., Auersperg, N., Tabassam, F.H., Roth, J.A., Gu, J., Fang, B., Mills, G.B. and Wolf, J. (2002). Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells Gynecol Oncol, 85: p. 451-8. [PMID: 12051873]

175. Tognon, C., Knezevich, S.R., Huntsman, D., Roskelley, C.D., Melnyk, N., Mathers, J.A., Becker, L., Carneiro, F., MacPherson, N., Horsman, D., Poremba, C. and Sorensen, P.H. (2002). Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma Cancer Cell, 2: p. 367-76. [PMID: 12450792]

176. Wong, A.S. and Auersperg, N. (2002). Normal ovarian surface epithelium Cancer Treat Res, 107: p. 161-83. [PMID: 11775449]

177. Auersperg, N., Wong, A.S., Choi, K.C., Kang, S.K. and Leung, P.C. (2001). Ovarian surface epithelium: biology, endocrinology, and pathology Endocr Rev, 22: p. 255-88. [PMID: 11294827]

178. Choi, K.C., Auersperg, N. and Leung, P.C. (2001). Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells J Clin Endocrinol Metab, 86: p. 5075-8. [PMID: 11600588]

179. Choi, K.C., Kang, S.K., Nathwani, P.S., Cheng, K.W., Auersperg, N. and Leung, P.C. (2001). Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE) Mol Cell Endocrinol, 174: p. 99-110. [PMID: 11306176]

180. Choi, K.C., Kang, S.K., Tai, C.J., Auersperg, N. and Leung, P.C. (2001). Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells Endocrinology, 142: p. 2351-60. [PMID: 11356682]

181. Choi, K.C., Kang, S.K., Tai, C.J., Auersperg, N. and Leung, P.C. (2001). The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium J Clin Endocrinol Metab, 86: p. 2125-35. [PMID: 11344217]

182. Hoskins, P.J., Swenerton, K.D., Pike, J.A., Wong, F., Lim, P., Acquino-Parsons, C. and Lee, N. (2001). Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study J Clin Oncol, 19: p. 4048-53. [PMID: 11600606]

183. Hu, Y.L., Tee, M.K., Goetzl, E.J., Auersperg, N., Mills, G.B., Ferrara, N. and Jaffe, R.B. (2001). Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells J Natl Cancer Inst, 93: p. 762-8. [PMID: 11353786]

184. Kang, S.K., Choi, K.C., Tai, C.J., Auersperg, N. and Leung, P.C. (2001). Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells Endocrinology, 142: p. 580-8. [PMID: 11159828]

185. Kang, S.K., Tai, C.J., Nathwani, P.S., Choi, K.C. and Leung, P.C. (2001). Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone in human granulosa-luteal cells Endocrinology, 142: p. 671-9. [PMID: 11159838]

186. Kang, S.K., Tai, C.J., Nathwani, P.S. and Leung, P.C. (2001). Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells Endocrinology, 142: p. 182-92. [PMID: 11145581]

187. Leung, E.H., Leung, P.C. and Auersperg, N. (2001). Differentiation and growth potential of human ovarian surface epithelial cells expressing temperature-sensitive SV40 T antigen In Vitro Cell Dev Biol Anim, 37: p. 515-21. [PMID: 11669285]

188. Lim, P., Al Kushi, A., Gilks, B., Wong, F. and Aquino-Parsons, C. (2001). Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome Cancer, 91: p. 752-7. [PMID: 11241243]

189. Stone, B., Schummer, M., Paley, P.J., Crawford, M., Ford, M., Urban, N. and Nelson, B.H. (2001). MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily Gene, 267: p. 173-82. [PMID: 11313144]

190. Tai, C.J., Kang, S.K., Choi, K.C., Tzeng, C.R. and Leung, P.C. (2001). Antigonadotropic action of adenosine triphosphate in human granulosa-luteal cells: involvement of protein kinase Calpha J Clin Endocrinol Metab, 86: p. 3237-42. [PMID: 11443195]

191. Tai, C.J., Kang, S.K., Choi, K.C., Tzeng, C.R. and Leung, P.C. (2001). Role of mitogen-activated protein kinase in prostaglandin f(2alpha) action in human granulosa-luteal cells J Clin Endocrinol Metab, 86: p. 375-80. [PMID: 11232027]

192. Tai, C.J., Kang, S.K. and Leung, P.C. (2001). Adenosine triphosphate-evoked cytosolic calcium oscillations in human granulosa-luteal cells: role of protein kinase C J Clin Endocrinol Metab, 86: p. 773-7. [PMID: 11158045]

193. Tai, C.J., Kang, S.K., Tzeng, C.R. and Leung, P.C. (2001). Adenosine triphosphate activates mitogen-activated protein kinase in human granulosa-luteal cells Endocrinology, 142: p. 1554-60. [PMID: 11250936]

194. Vaananen, J.E., Tong, B.L., Vaananen, C.C., Chan, I.H., Yuen, B.H. and Leung, P.C. (2001). Interaction of prostaglandin F(2alpha) and prostaglandin E(2) on progesterone production in human granulosa-luteal cells Biol Signals Recept, 10: p. 380-8. [PMID: 11721093]

195. Wong, A.S., Kim, S.O., Leung, P.C., Auersperg, N. and Pelech, S.L. (2001). Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium Gynecol Oncol, 82: p. 305-11. [PMID: 11531284]

196. Wong, A.S., Pelech, S.L., Woo, M.M., Yim, G., Rosen, B., Ehlen, T., Leung, P.C. and Auersperg, N. (2001). Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis? Oncogene, 20: p. 1318-28. [PMID: 11313876]

197. Woo, M.M., Tai, C.J., Kang, S.K., Nathwani, P.S., Pang, S.F. and Leung, P.C. (2001). Direct action of melatonin in human granulosa-luteal cells J Clin Endocrinol Metab, 86: p. 4789-97. [PMID: 11600542]

198. Chiang, C.H., Cheng, K.W., Igarashi, S., Nathwani, P.S. and Leung, P.C. (2000). Hormonal regulation of estrogen receptor alpha and beta gene expression in human granulosa-luteal cells in vitro J Clin Endocrinol Metab, 85: p. 3828-39. [PMID: 11061546]

199. Irving, J.A., McFarland, D.F., Stuart, D.S. and Gilks, C.B. (2000). Mitotic arrest of endometrial epithelium after paclitaxel therapy for breast cancer Int J Gynecol Pathol, 19: p. 395-7. [PMID: 11109173]

200. Ito, I., Minegishi, T., Fukuda, J., Shinozaki, H., Auersperg, N. and Leung, P.C. (2000). Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma Br J Cancer, 82: p. 1415-20. [PMID: 10780520]

201. Kang, S.K., Choi, K.C., Cheng, K.W., Nathwani, P.S., Auersperg, N. and Leung, P.C. (2000). Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium Endocrinology, 141: p. 72-80. [PMID: 10614625]

202. Kang, S.K., Tai, C.J., Cheng, K.W. and Leung, P.C. (2000). Gonadotropin-releasing hormone activates mitogen-activated protein kinase in human ovarian and placental cells Mol Cell Endocrinol, 170: p. 143-51. [PMID: 11162898]

203. Nathwani, P.S., Kang, S.K., Cheng, K.W., Choi, K.C. and Leung, P.C. (2000). Regulation of gonadotropin-releasing hormone and its receptor gene expression by 17beta-estradiol in cultured human granulosa-luteal cells Endocrinology, 141: p. 1754-63. [PMID: 10803586]

204. Ong, A., Maines-Bandiera, S.L., Roskelley, C.D. and Auersperg, N. (2000). An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium Int J Cancer, 85: p. 430-7. [PMID: 10652437]

205. Piccart, M.J., Bertelsen, K., James, K., Cassidy, J., Mangioni, C., Simonsen, E., Stuart, G., Kaye, S., Vergote, I., Blom, R., Grimshaw, R., Atkinson, R.J., Swenerton, K.D., Trope, C., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J.A., Lhoas, F., Lindvall, B., Bacon, M., Birt, A. andersen, J.E., Zee, B., Paul, J., Baron, B. and Pecorelli, S. (2000). Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results J Natl Cancer Inst, 92: p. 699-708. [PMID: 10793106]

206. Tai, C.J., Kang, S.K., Cheng, K.W., Choi, K.C., Nathwani, P.S. and Leung, P.C. (2000). Expression and regulation of P2U-purinergic receptor in human granulosa-luteal cells J Clin Endocrinol Metab, 85: p. 1591-7. [PMID: 10770202]

207. Wong, A.S., Leung, P.C. and Auersperg, N. (2000). Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells Gynecol Oncol, 78: p. 158-65. [PMID: 10926796]

208. Auersperg, N., Pan, J., Grove, B.D., Peterson, T., Fisher, J., Maines-Bandiera, S., Somasiri, A. and Roskelley, C.D. (1999). E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium Proc Natl Acad Sci U S A, 96: p. 6249-54. [PMID: 10339573]

209. Cruet, S., Salamanca, C., Mitchell, G.W. and Auersperg, N. (1999). alphavbeta3 and vitronectin expression by normal ovarian surface epithelial cells: role in cell adhesion and cell proliferation Gynecol Oncol, 75: p. 254-60. [PMID: 10525382]

210. Huntsman, D., Resau, J.H., Klineberg, E. and Auersperg, N. (1999). Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy Am J Pathol, 155: p. 343-8. [PMID: 10433927]

211. Kruk, P.A., Godwin, A.K., Hamilton, T.C. and Auersperg, N. (1999). Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer Gynecol Oncol, 73: p. 229-36. [PMID: 10329039]

212. McClellan, M., Kievit, P., Auersperg, N. and Rodland, K. (1999). Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells Exp Cell Res, 246: p. 471-9. [PMID: 9925763]

213. Peng, C., Ohno, T., Koh, L.Y., Chen, V.T. and Leung, P.C. (1999). Human ovary and placenta express messenger RNA for multiple activin receptors Life Sci, 64: p. 983-94. [PMID: 10210281]

214. Piccart, M.J., Stuart, G.C., Cassidy, J., Bertelsen, K., Parmar, M.K., Eisenhauer, E.A., Kaye, S.B., Trope, C., Swenerton, K., Harper, P. and Vermorken, J.B. (1999). Intergroup collaboration in ovarian cancer: a giant step forward Ann Oncol, 10 Suppl 1: p. 83-6. [PMID: 10219459]

215. Wong, A.S., Maines-Bandiera, S.L., Rosen, B., Wheelock, M.J., Johnson, K.R., Leung, P.C., Roskelley, C.D. and Auersperg, N. (1999). Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer Int J Cancer, 81: p. 180-8. [PMID: 10188716]

216. Auersperg, N., Edelson, M.I., Mok, S.C., Johnson, S.W. and Hamilton, T.C. (1998). The biology of ovarian cancer Semin Oncol, 25: p. 281-304. [PMID: 9633841]

217. Davies, B.R., Auersperg, N., Worsley, S.D. and Ponder, B.A. (1998). Transfection of rat ovarian surface epithelium with erb-B2/neu induces transformed phenotypes in vitro and the tumorigenic phenotype in vivo Am J Pathol, 152: p. 297-306. [PMID: 9422547]

218. Pan, J. and Auersperg, N. (1998). Spatiotemporal changes in cytokeratin expression in the neonatal rat ovary Biochem Cell Biol, 76: p. 27-35. [PMID: 9666303]

219. Vaananen, J.E., Lee, S., Vaananen, C.C., Yuen, B.H. and Leung, P.C. (1998). Stepwise activation of the gonadotropic signal transduction pathway, and the ability of prostaglandin F2alpha to inhibit this activated pathway Endocrine, 8: p. 301-7. [PMID: 9741835]

220. Vaananen, J.E., Vaananen, C.C., Lee, S., Yuen, B.H. and Leung, P.C. (1998). Regulation of prostaglandin F2alpha-receptor mRNA in human granulosa-luteal cells by human chorionic gonadotrophin and prostaglandin F2alpha Endocrine, 8: p. 261-7. [PMID: 9741831]

221. Wehrli, B.M., Krajewski, S., Gascoyne, R.D., Reed, J.C. and Gilks, C.B. (1998). Immunohistochemical analysis of bcl-2, bax, mcl-1, and bcl-X expression in ovarian surface epithelial tumors Int J Gynecol Pathol, 17: p. 255-60. [PMID: 9656122]

222. Wong, A.S., Leung, P.C., Maines-Bandiera, S.L. and Auersperg, N. (1998). Metaplastic changes in cultured human ovarian surface epithelium In Vitro Cell Dev Biol Anim, 34: p. 668-70. [PMID: 9794215]

223. Yin, H., Cheng, K.W., Hwa, H.L., Peng, C., Auersperg, N. and Leung, P.C. (1998). Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines Life Sci, 62: p. 2015-23. [PMID: 9627100]

224. Al-Hendy, A. and Auersperg, N. (1997). Applying the herpes simplex virus thymidine kinase/ganciclovir approach to ovarian cancer: an effective in vitro drug-sensitization system Gynecol Obstet Invest, 43: p. 268-75. [PMID: 9194627]

225. Al-Saleh, E., Hoskins, P.J., Pike, J.A. and Swenerton, K.D. (1997). Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma Gynecol Oncol, 64: p. 468-72. [PMID: 9062152]

226. Auersperg, N., Maines-Bandiera, S.L. and Dyck, H.G. (1997). Ovarian carcinogenesis and the biology of ovarian surface epithelium J Cell Physiol, 173: p. 261-5. [PMID: 9365533]

227. Dadmanesh, F., Miller, D.M., Swenerton, K.D. and Clement, P.B. (1997). Gliomatosis peritonei with malignant transformation Mod Pathol, 10: p. 597-601. [PMID: 9195578]

228. Leung, E.H., Davies, B.R., Leung, P.C., Chen, G.T., Roskelley, C.D. and Auersperg, N. (1997). Efficient introduction of genes into human ovarian surface epithelium In Vitro Cell Dev Biol Anim, 33: p. 665-7. [PMID: 9358278]

229. Maines-Bandiera, S.L. and Auersperg, N. (1997). Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia? Int J Gynecol Pathol, 16: p. 250-5. [PMID: 9421091]

230. Miller, D.M., Ehlen, T.G. and Saleh, E.A. (1997). Successful term pregnancy following conservative debulking surgery for a stage IIIA serous low-malignant-potential tumor of the ovary: a case report Gynecol Oncol, 66: p. 535-8. [PMID: 9299273]

231. Squires, P.E., Lee, P.S., Yuen, B.H., Leung, P.C. and Buchan, A.M. (1997). Mechanisms involved in ATP-evoked Ca2+ oscillations in isolated human granulosa-luteal cells Cell Calcium, 21: p. 365-74. [PMID: 9174649]

232. Vaananen, J.E., Tong, B.L., Vaananen, C.M., Chan, I.H., Yuen, B.H. and Leung, P.C. (1997). Interaction of prostaglandin F2alpha and gonadotropin-releasing hormone on progesterone and estradiol production in human granulosa-luteal cells Biol Reprod, 57: p. 1346-53. [PMID: 9408239]

233. Dyck, H.G., Hamilton, T.C., Godwin, A.K., Lynch, H.T., Maines-Bandiera, S. and Auersperg, N. (1996). Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer Int J Cancer, 69: p. 429-36. [PMID: 8980241]

234. Hoskins, P.J., Swenerton, K.D., Pike, J.A., McMurtrie, E.M. and Lee, N. (1996). "MECCA": a developmental, dose-intensive, non-cross-resistant platinum-based chemotherapy for advanced ovarian cancer Gynecol Oncol, 63: p. 345-51. [PMID: 8946870]

235. Lee, P.S., Squires, P.E., Buchan, A.M., Yuen, B.H. and Leung, P.C. (1996). P2-purinoreceptor evoked changes in intracellular calcium oscillations in single isolated human granulosa-lutein cells Endocrinology, 137: p. 3756-61. [PMID: 8756543]

236. Lie, B.L., Leung, E., Leung, P.C. and Auersperg, N. (1996). Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen Mol Cell Endocrinol, 120: p. 169-76. [PMID: 8832577]

237. Peng, C., Ohno, T., Khorasheh, S. and Leung, P.C. (1996). Activin and follistatin as local regulators in the human ovary Biol Signals, 5: p. 81-9. [PMID: 8836491]

238. Swenerton, K., Hoskins, P., Stuart, G., Batist, G., Pike, J., Onetto, N., Fisher, B. and Eisenhauer, E. (1996). A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group Ann Oncol, 7: p. 1077-9. [PMID: 9037368]

239. Treissman, M.J., Miller, D. and McComb, P.F. (1996). Laparoscopic lateral ovarian transposition Fertil Steril, 65: p. 1229-31. [PMID: 8641503]

240. Woo, H.L., Swenerton, K.D. and Hoskins, P.J. (1996). Taxol is active in platinum-resistant endometrial adenocarcinoma Am J Clin Oncol, 19: p. 290-1. [PMID: 8638543]

241. Auersperg, N., Maines-Bandiera, S., Booth, J.H., Lynch, H.T., Godwin, A.K. and Hamilton, T.C. (1995). Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer Am J Obstet Gynecol, 173: p. 558-65. [PMID: 7645635]

242. Gordon, A.W., Pegues, J.C., Johnson, G.R., Kannan, B., Auersperg, N. and Stromberg, K. (1995). mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells Cancer Lett, 89: p. 63-71. [PMID: 7882303]

243. Hoskins, P.J., Swenerton, K.D., Wong, F., Manji, M.F., McMurtrie, E.M., Le, N. and Pike, J. (1995). Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade) Int J Gynecol Cancer, 5: p. 134-142. [PMID: 11578468]

244. Hoskins, P.J., Wong, F., Swenerton, K.D., Pike, J.A., Manji, M., McMurtrie, E., Acker, B. and Le Riche, J. (1995). Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide Gynecol Oncol, 56: p. 218-25. [PMID: 7896189]

245. Olofsson, J.I., Conti, C.C. and Leung, P.C. (1995). Homologous and heterologous regulation of gonadotropin-releasing hormone receptor gene expression in preovulatory rat granulosa cells Endocrinology, 136: p. 974-80. [PMID: 7867607]

246. Pan, J., Kwan, R.W. and Auersperg, N. (1995). Keratin expression and steroidogenesis in rat granulosa cells, transformed with the Kirsten-ras and SV40 oncogenes singly and in combination Mol Cell Endocrinol, 112: p. 231-9. [PMID: 7489827]

247. Pan, J., Roskelley, C.D. and Auersperg, N. (1995). Influence of cell type on the steroidogenic potential and basal cyclic AMP levels of ras-oncogene-transformed rat cells Differentiation, 58: p. 321-8. [PMID: 7622009]

248. Auersperg, N., Maines-Bandiera, S.L., Dyck, H.G. and Kruk, P.A. (1994). Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes Lab Invest, 71: p. 510-8. [PMID: 7967506]

249. Cooper, J.K., Wong, F.L. and Swenerton, K.D. (1994). Endometrial adenocarcinoma presenting as an isolated calcaneal metastasis. A rare entity with good prognosis Cancer, 73: p. 2779-81. [PMID: 8194019]

250. Egorin, M.J., Reyno, L.M., Canetta, R.M., Jodrell, D.I., Swenerton, K.D., Pater, J.L., Burroughs, J.N., Novak, M.J. and Sridhara, R. (1994). Modeling toxicity and response in carboplatin-based combination chemotherapy Semin Oncol, 21: p. 7-19. [PMID: 7992070]

251. Eisenhauer, E.A., ten Bokkel Huinink, W.W., Swenerton, K.D., Gianni, L., Myles, J., van der Burg, M.E., Kerr, I., Vermorken, J.B., Buser, K., Colombo, N. and et al. (1994). European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion J Clin Oncol, 12: p. 2654-66. [PMID: 7989941]

252. Hoskins, P.J. and Swenerton, K.D. (1994). Oral etoposide is active against platinum-resistant epithelial ovarian cancer J Clin Oncol, 12: p. 60-3. [PMID: 8270985]

253. Hoskins, P.J., Swenerton, K.D., Manji, M., Wong, F., O'Reilly, S.E., McMurtrie, E.J., Le, N., Acker, B. and Le Richer, J. (1994). 'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation Int J Gynecol Cancer, 4: p. 272-278. [PMID: 11578417]

254. Huntsman, D.G., Clement, P.B., Gilks, C.B. and Scully, R.E. (1994). Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases Am J Surg Pathol, 18: p. 364-75. [PMID: 7511354]

255. Kruk, P.A. and Auersperg, N. (1994). A line of rat ovarian surface epithelium provides a continuous source of complex extracellular matrix In Vitro Cell Dev Biol Anim, 30A: p. 217-25. [PMID: 8069444]

256. Kruk, P.A., Uitto, V.J., Firth, J.D., Dedhar, S. and Auersperg, N. (1994). Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix Exp Cell Res, 215: p. 97-108. [PMID: 7525326]

257. Peng, C., Fan, N.C., Ligier, M., Vaananen, J. and Leung, P.C. (1994). Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells Endocrinology, 135: p. 1740-6. [PMID: 7956897]

258. Elliott, W.M. and Auersperg, N. (1993). Comparison of the neutral red and methylene blue assays to study cell growth in culture Biotech Histochem, 68: p. 29-35. [PMID: 7680581]

259. Elliott, W.M. and Auersperg, N. (1993). Growth of normal human ovarian surface epithelial cells in reduced-serum and serum-free media In Vitro Cell Dev Biol, 29A: p. 9-18. [PMID: 7680339]

260. Hoffman, A.G., Burghardt, R.C., Tilley, R. and Auersperg, N. (1993). An in vitro model of ovarian epithelial carcinogenesis: changes in cell-cell communication and adhesion occurring during neoplastic progression Int J Cancer, 54: p. 828-38. [PMID: 8325708]

261. Li, W., Khorasheh, S., Yuen, B.H., Ling, N. and Leung, P.C. (1993). Stimulation of progesterone secretion by recombinant follistatin-288 in human granulosa cells Endocrinology, 132: p. 1750-6. [PMID: 8384994]

262. Porter, S. and Gilks, C.B. (1993). Genomic imprinting: a proposed explanation for the different behaviours of testicular and ovarian germ cell tumors Med Hypotheses, 41: p. 37-41. [PMID: 8231978]

263. Reyno, L.M., Egorin, M.J., Canetta, R.M., Jodrell, D.I., Swenerton, K.D., Pater, J.L., Burroughs, J.N., Novak, M.J. and Sridhara, R. (1993). Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer J Clin Oncol, 11: p. 1156-64. [PMID: 8501502]

264. Rusthoven, J.J., Eisenhauer, E., Mazurka, J., Hirte, H., O'Connell, G., Muldal, A., Lu, H.X., Onetto, N., Swenerton, K. and Jeffrey, J. (1993). Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinoma J Natl Cancer Inst, 85: p. 823-5. [PMID: 8487328]

265. ten Bokkel Huinink, W.W., Eisenhauer, E. and Swenerton, K. (1993). Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer. Canadian-European Taxol Cooperative Trial Group Cancer Treat Rev, 19 Suppl C: p. 79-86. [PMID: 8106156]

266. Ziltener, H.J., Maines-Bandiera, S., Schrader, J.W. and Auersperg, N. (1993). Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium Biol Reprod, 49: p. 635-41. [PMID: 7691194]

267. Currie, W.D., Li, W., Baimbridge, K.G., Yuen, B.H. and Leung, P.C. (1992). Cytosolic free calcium increased by prostaglandin F2 alpha (PGF2 alpha), gonadotropin-releasing hormone, and angiotensin II in rat granulosa cells and PGF2 alpha in human granulosa cells Endocrinology, 130: p. 1837-43. [PMID: 1547713]

268. Gilks, C.B. and Clement, P.B. (1992). Papillary serous adenocarcinoma of the uterine cervix: a report of three cases Mod Pathol, 5: p. 426-31. [PMID: 1495949]

269. Hornby, A.E., Pan, J. and Auersperg, N. (1992). Intermediate filaments in rat ovarian surface epithelial cells: changes with neoplastic progression in culture Biochem Cell Biol, 70: p. 16-25. [PMID: 1374615]

270. Hoskins, P.J., McMurtrie, E. and Swenerton, K.D. (1992). A phase II trial of intravenous etoposide (VP-16-213) in epithelial ovarian cancer resistant to cisplatin or carboplatin: clinical and serological evidence of activity Int J Gynecol Cancer, 2: p. 35-40. [PMID: 11576232]

271. Hoskins, P.J., O'Reilly, S.E., Swenerton, K.D., Spinelli, J.J., Fairey, R.N. and Benedet, J.L. (1992). Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy J Clin Oncol, 10: p. 1561-8. [PMID: 1403035]

272. Kruk, P.A. and Auersperg, N. (1992). Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix Am J Obstet Gynecol, 167: p. 1437-43. [PMID: 1443002]

273. Li, W., Yuen, B.H. and Leung, P.C. (1992). Inhibition of progestin accumulation by activin-A in human granulosa cells J Clin Endocrinol Metab, 75: p. 285-9. [PMID: 1320053]

274. Maines-Bandiera, S.L., Kruk, P.A. and Auersperg, N. (1992). Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix Am J Obstet Gynecol, 167: p. 729-35. [PMID: 1326894]

275. Pan, J., Roskelley, C.D., Luu-The, V., Rojiani, M. and Auersperg, N. (1992). Reversal of divergent differentiation by ras oncogene-mediated transformation Cancer Res, 52: p. 4269-72. [PMID: 1379124]

276. Rodway, M.R., Steele, G.L., Baimbridge, K.G. and Leung, P.C. (1992). Prostaglandin F2 alpha and gonadotropin-releasing hormone increase intracellular free calcium in rat granulosa cells Mol Cell Endocrinol, 84: p. 137-43. [PMID: 1639216]

277. Swenerton, K., Jeffrey, J., Stuart, G., Roy, M., Krepart, G., Carmichael, J., Drouin, P., Stanimir, R., O'Connell, G., MacLean, G. and et al. (1992). Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol, 10: p. 718-26. [PMID: 1569444]

278. Swenerton, K.D. (1992). Prognostic indices in ovarian cancer. Their significance in treatment planning Acta Obstet Gynecol Scand Suppl, 155: p. 67-74. [PMID: 1502892]

279. Swenerton, K.D. and Pater, J.L. (1992). Carboplatin in the treatment of carcinoma of the ovary: the National Cancer Institute of Canada experience. Ovarian Cancer Subcommittee Semin Oncol, 19: p. 114-9. [PMID: 1411622]

280. Wang, J., Steele, G.L., Baimbridge, K.G., Rodway, M.R. and Leung, P.C. (1992). Intracellular calcium and the signaling mechanism of luteinizing hormone-releasing hormone in rat granulosa cells Am J Obstet Gynecol, 167: p. 541-7. [PMID: 1497067]

281. Auersperg, N., Maclaren, I.A. and Kruk, P.A. (1991). Ovarian surface epithelium: autonomous production of connective tissue-type extracellular matrix Biol Reprod, 44: p. 717-24. [PMID: 1710511]

282. Johnson, G.R., Saeki, T., Auersperg, N., Gordon, A.W., Shoyab, M., Salomon, D.S. and Stromberg, K. (1991). Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin Biochem Biophys Res Commun, 180: p. 481-8. [PMID: 1953719]

283. Sutton, R.A., Walker, V.R., Halabe, A., Swenerton, K. and Coppin, C.M. (1991). Chronic hypomagnesemia caused by cisplatin: effect of calcitriol J Lab Clin Med, 117: p. 40-3. [PMID: 1987306]

284. Young, R.H., Gilks, C.B. and Scully, R.E. (1991). Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix Am J Surg Pathol, 15: p. 415-29. [PMID: 2035736]

285. Gilks, C.B., Bell, D.A. and Scully, R.E. (1990). Serous psammocarcinoma of the ovary and peritoneum Int J Gynecol Pathol, 9: p. 110-21. [PMID: 2332269]

286. Hoskins, P.J., McMurtrie, E. and Swenerton, K.D. (1990). A phase II trial of mitomycin in patients with epithelial ovarian carcinoma resistant to cisplatin or carboplatin Am J Clin Oncol, 13: p. 416-9. [PMID: 2220661]

287. Kruk, P.A., Maines-Bandiera, S.L. and Auersperg, N. (1990). A simplified method to culture human ovarian surface epithelium Lab Invest, 63: p. 132-6. [PMID: 2374399]